Efficacy and safety of glucagon-like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: an umbrella review and evidence map of randomised controlled trials
Yeo D, Jo Y, Jeong J, et al.
Diabetes Obes Metab. Pub. online 19 Nov 2025.
Leggi


